Severe Flu Season Provides an Opportunity for Molecular POC

Severe Flu Season Provides an Opportunity for Molecular POC

Molecular POC systems get their chance to prove themselves in a severe flu season, says analyst Rob Camp: "The gold standard for diagnostics is real-time PCR, but...PCR is time-consuming, because of the preparation and the complexity of its mechanism...So for a few years now, big biotech firms have been working on better solutions, employing nucleic acid amplification techniques that make PCR so accurate and engineering them into relatively tiny and simple packages"


Big Events in Biosimilars

Big Events in Biosimilars

Two big events in the news involving biosimilars: a large deal and an important approval


Biotechnology Fights HAI

Biotechnology Fights HAI

illnesses that are most commonly acquired in hospital settings are a formidable foe, but biotech is ready, as this article details.

  • by Bruce Carlson
  • January 8 2018
  • ACA


$185 Billion-Dollar U.S. Medical Device Industry Reckons With Return of Tax

$185 Billion-Dollar U.S. Medical Device Industry Reckons With Return of Tax

Surprise! The new year arrived with the return of a new tax for device makers who manufacture and sell into the U.S., as well as those who import into the largest medical device market. We examine the effects, and some good news, in this article.